Hi-Tech Pharmacal (HITK)
Add to Watchlists Create an Alert
33.81
+0.07 +0.21%
NASDAQ
May 22, 8:00PM
BATS Real time
Currency in USD
Hi-Tech Pharmacal Debt to Equity Ratio:
0.0054 for Jan. 31, 2013Hi-Tech Pharmacal Historical Debt to Equity Ratio Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Jan. 31, 2013 | 0.0054 |
| Oct. 31, 2012 | 0.0055 |
| July 31, 2012 | 0.0061 |
| April 30, 2012 | 0.0068 |
| Jan. 31, 2012 | 0.0074 |
| Oct. 31, 2011 | 0.0084 |
| July 31, 2011 | 0.0032 |
| April 30, 2011 | 0.0002 |
| Jan. 31, 2011 | 0.0042 |
| Oct. 31, 2010 | 0.0049 |
| July 31, 2010 | 0.0056 |
| April 30, 2010 | 0.00 |
| Jan. 31, 2010 | 0.00 |
| Oct. 31, 2009 | 0.00 |
| July 31, 2009 | 0.0218 |
| April 30, 2009 | 0.0479 |
| Jan. 31, 2009 | 0.0056 |
| Oct. 31, 2008 | 0.0063 |
| July 31, 2008 | 0.0062 |
| April 30, 2008 | Go Pro |
| Jan. 31, 2008 | Go Pro |
| Oct. 31, 2007 | Go Pro |
| July 31, 2007 | Go Pro |
| April 30, 2007 | Go Pro |
| Jan. 31, 2007 | Go Pro |
| Oct. 31, 2006 | Go Pro |
| July 31, 2006 | Go Pro |
| April 30, 2006 | Go Pro |
| Jan. 31, 2006 | Go Pro |
| Oct. 31, 2005 | Go Pro |
| July 31, 2005 | Go Pro |
| April 30, 2005 | Go Pro |
| Jan. 31, 2005 | Go Pro |
| Oct. 31, 2004 | Go Pro |
| July 31, 2004 | Go Pro |
| April 30, 2004 | Go Pro |
| Jan. 31, 2004 | Go Pro |
| Oct. 31, 2003 | Go Pro |
| July 31, 2003 | Go Pro |
| April 30, 2003 | Go Pro |
| Jan. 31, 2003 | Go Pro |
| Oct. 31, 2002 | Go Pro |
| July 31, 2002 | Go Pro |
| April 30, 2002 | Go Pro |
| Jan. 31, 2002 | Go Pro |
| Oct. 31, 2001 | Go Pro |
| July 31, 2001 | Go Pro |
| April 30, 2001 | Go Pro |
| Jan. 31, 2001 | Go Pro |
| Oct. 31, 2000 | Go Pro |
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
HITK Debt to Equity Ratio Benchmarks
| Companies | |
|---|---|
| Columbia Laboratories | 0.00 |
| SciClone Pharmaceuticals | 0.0101 |
| Sagent Pharmaceuticals | 0.00 |
HITK Debt to Equity Ratio Rankings
| Overall |
82nd percentile 1429 of 8005 |
| Sector |
65th percentile 234 of 686 in Healthcare |
| Industry |
60th percentile 27 of 68 in Drug Manufacturers - Specialty & Generic |
HITK Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.00 | Oct 2009 |
| Maximum | 0.0479 | Apr 2009 |
| Average | 0.0077 |